SCHEMBL7974508

SCHEMBL7974508

O=c1nc(-c2ccc(F)cc2)[nH]c2ncn(Cc3ccccc3)c12

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNOT7 Q9UIV1 4/20 0.51
PARN O95453 1/20 0.51
SMN1; SMN2 Q16637 4/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
PNP P00491 2/20 0.43
ALDH1A1 P00352 3/20 0.43
TNKS O95271 1/20 0.42
TNKS2 Q9H2K2 1/20 0.42
PARP2 Q9UGN5 1/20 0.42
ACP1 P24666 1/20 0.41
HPGD P15428 1/20 0.41
LMNA P02545 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
KDM4E B2RXH2 1/20 0.39
ADORA2B P29275 1/20 0.39
RXFP1 Q9HBX9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7986522 0.95 CNOT7 (0.48) CNOT7PARNSMN1; SMN2L3MBTL1PNP
SCHEMBL7984283 0.94 CNOT7 (0.43) CNOT7PARNSMN1; SMN2L3MBTL1ALDH1A1
SCHEMBL7975271 0.92 CNOT7 (0.56) CNOT7PARNSMN1; SMN2PNPALDH1A1
SCHEMBL7988644 0.90 GRIN1 (0.42) CNOT7PARNSMN1; SMN2ALDH1A1ACP1
SCHEMBL7975135 0.89 CNOT7 (0.52) CNOT7PARNSMN1; SMN2PNPALDH1A1
SCHEMBL7984461 0.89 CNOT7 (0.52) CNOT7PARNSMN1; SMN2PNPALDH1A1
SCHEMBL7988820 0.89 MAPK1 (0.48) CNOT7PARNSMN1; SMN2L3MBTL1ACP1
SCHEMBL7985168 0.89 KMT2A (0.46) CNOT7PARNALDH1A1ACP1KMT2A
SCHEMBL7973875 0.89 CNOT7 (0.53) CNOT7PARNALDH1A1TNKSTNKS2
SCHEMBL7988562 0.88 CNOT7 (0.54) CNOT7PARNSMN1; SMN2PNPALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed